TGFB1 and neoplasm: In the TME, TGF-β not only promotes angiogenic and epithelial-mesenchymal transition (EMT) malignant phenotypes 145, it also serves as a crucial immunosuppressive factor that inhibits the tumor infiltration of immune cells, including the suppression of NK cell activity 146.